Abstract
Syphilis and HIV are both diseases of major public health importance globally, affecting tens of millions of people and leading to millions of deaths every year. There is a complex demographic, epidemiologic, and biologic interaction between the HIV virus and Treponema pallidum, the causative agent of syphilis. These interactions lead not only to higher rates of coinfection but also are believed to affect pathogenic mechanisms that result in early central nervous system syphilis among HIV-coinfected patients. Acute syphilitic meningitis and neuro-ophthalmologic syphilitic involvement are also believed to occur at a higher rate and early in the course of syphilis among HIV-coinfected individuals. There needs to be a higher index of suspicion for syphilitic involvement of the CNS among HIV patients especially those with ophthalmological and/or ontological complaints. While there may need to be subtle differences, current recommendations for diagnostic workup for neurosyphilis in HIV-coinfected patients are similar to that of non-HIV patients. Intravenous penicillin remains the treatment of choice for neurosyphilis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
World Health Organization (2012) Global incidence and prevalence of selected curable sexually transmitted infections-2008. World Health Organization
Dickerson MC, Johnston J, Delea TE et al (1996) The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus: an application of the Bradford hill criteria. Sex Transm Dis 23:429–440
Nnoruka EN, Ezeoke A (2005) Evaluation of syphilis in patients with HIV infection in Nigeria. Tropical Med Int Health 10:58–64
Shimelis T, Lemma K, Ambachew H et al (2015) Syphilis among people with HIV infection in southern ethiopia: sero-prevalence and risk factors. BMC Infect Dis 15:1
Firlag-Burkacka E, Cielniak I, Swiecki P et al (2013) The increasing prevalence of neurosyphilis and high serum VDRL titers in HIV positive patients—Data from outpatient clinic in Warsaw, Poland (POLCA cohort). HIV & AIDS Rev 12:34–36
Tucker JD, Chen X, Peeling RW (2010) Syphilis and social upheaval in China. N Engl J Med 362:1658–1661
Piot P, Bartos M, Ghys PD et al (2001) The global impact of HIV/AIDS. Nature 410:968–973
Ortblad KF, Lozano R, Murray CJ (2013) The burden of HIV: insights from the global burden of disease study 2010. AIDS 27:2003–2017
Chesson HW, Heffelfinger JD, Voigt RF et al (2005) Estimates of primary and secondary syphilis rates in persons with HIV in the united states, 2002. Sex Transm Dis 32:265–269
Blocker ME, Levine WC, Louis MES (2000) HIV prevalence in patients with syphilis, United States. Sex Transm Dis 27:53–59
Hutchinson CM, Hook EW, Shepherd M et al (1994) Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 121:9
Wu L, Paxton WA, Kassam N et al (1997) CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 185:1681–1692
Sellati TJ, Wilkinson DA, Sheffield JS et al (2000) Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J Infect Dis 181:283–293
Johns DR, Tierney M, Felsenstein D (1987) Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 316:1569–1572
Collart P, Franceschini P, Durel P (1971) Experimental rabbit syphilis. Br J Vener Dis 47:389
Lukehart SA, Hook EW, Baker-Zander SA et al (1988) Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 109:855–862
Chesney AM, Kemp JE (1924) Incidence of spirochaeta pallida in cerebrospinal fluid during early stage of syphilis. J Am Med Assoc 83:1725–1728
Chung KY, Lee MG, Lee JB (1994) Detection of Treponema pallidum by polymerase chain reaction in the cerebrospinal fluid of syphilis patients. Yonsei Med J 35:190
Ghanem KG (2010) REVIEW: Neurosyphilis: a historical perspective and review. CNS Neurosci Ther 16:e168
Keidel A (1922) Studies in asymptomatic neurosyphilis: IV. The apparent role of immunity in the genesis of neurosyphilis. J Am Med Assoc 79:874–876
Amaratunge BC, Camuglia JE, Hall AJ (2010) Syphilitic uveitis: a review of clinical manifestations and treatment outcomes of syphilitic uveitis in human immunodeficiency virus-positive and negative patients. Clin Experiment Ophthalmol 38:68–74
Flood JM, Weinstock HS, Guroy ME et al (1998) Neurosyphilis during the AIDS epidemic, San Francisco, 1985–1992. J Infect Dis 177:931–940
Ghanem KG, Moore RD, Rompalo AM et al (2008) Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 22:1145
Rolfs RT (1995) Treatment of syphilis, 1993. Clin Infect Dis 20:S38
Rolfs RT, Joesoef MR, Hendershot EF et al (1997) A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 337:307–314
Feraru ER, Aronow HA, Lipton RB (1990) Neurosyphilis in AIDS patients Initial CSF VDRL may be negative. Neurology 40(3 Part 1):541–541
Blanco DR, Miller JN, Lovett MA (1997) Surface antigens of the syphilis spirochete and their potential as virulence determinants. Emerg Infect Dis 3:11
Fraser CM, Norris SJ, Weinstock GM et al (1998) Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 281:375–388
Cox DL, Chang P, McDowall AW et al (1992) The outer membrane, not a coat of host proteins, limits antigenicity of virulent Treponema pallidum. Infect Immun 60:1076–1083
Chamberlain NR, Brandt ME, Erwin AL et al (1989) Major integral membrane protein immunogens of Treponema pallidum are proteolipids. Infect Immun 57:2872–2877
Murphy PM (2001) Viral exploitation and subversion of the immune system through chemokine mimicry. Nat Immunol 2:116–122
Ke W, Molini BJ, Lukehart SA et al (2015) Treponema pallidum subsp. pallidum TP0136 protein is heterogeneous among isolates and binds cellular and plasma fibronectin via its NH 2-terminal end. PLoS Negl Trop Dis 9:e0003662
Baseman JB, Alderete JF (1983) The parasitic strategies of Treponema pallidum. In: Schell D, Museher R (eds) Immunology of Treponema infections, vol 20. Marcel Dekker, Inc., New York, p 229
Cameron CE (2003) Identification of a Treponema pallidum laminin-binding protein. Infect Immun 71:2525–2533
Riley BS, Oppenheimer-Marks N, Hansen EJ et al (1992) Virulent Treponema pallidum activates human vascular endothelial cells. J Infect Dis 165:484–493
Zhang R, Wang Q, Zhang J et al (2015) Tp17 membrane protein of Treponema pallidum activates endothelial cells in vitro. Int Immunopharmacol 25:538–544
Centers for Disease Control and Prevention (CDC) (2007) Symptomatic early neurosyphilis among HIV-positive men who have sex with men – four cities, United States, January 2002-June 2004. MMWR Morb Mortal Wkly Rep 56:625
Adams RD, Merritt HH (1944) Meningeal and vascular syphilis of the spinal cord. Medicine 23:181–214
Clark EG, Danbolt N (1955) The oslo study of the natural history of untreated syphilis: an epidemiologic investigation based on a restudy of the Boeck-Bruusgaard material a review and appraisal. J Chronic Dis 2:311–344
Bayne LL, Schmidley JW, Goodin DS (1986) Acute syphilitic meningitis: its occurrence after clinical and serologic cure of secondary syphilis with penicillin G. Arch Neurol 43:137–138
Weinert LS, Scheffel RS, Zoratto G et al (2008) Cerebral syphilitic gumma in HIV-infected patients: case report and review. Int J STD AIDS 19:62–64
Philip SS, Klausner JD. Neurosyphilis in HIV-infected patients. 2008.
Mishra S, Walmsley SL, Loutfy MR et al (2008) Otosyphilis in HIV-coinfected individuals: a case series from Toronto, Canada. AIDS Patient Care STDs 22:213–219
Poliseli R, Vidal JE, De O, Penalva AC et al (2008) Neurosyphilis in HIV-infected patients: clinical manifestations, serum venereal disease research laboratory titers, and associated factors to symptomatic neurosyphilis. Sex Transm Dis 35:425–429
Balba GP, Kumar PN, James AN et al (2006) Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy. Am J Med 119:448.E25
Marra CM (2004) Neurosyphilis. Curr Neurol Neurosci Rep 4:435–440
Kiss S, Damico FM, Young LH (2005) Ocular manifestations and treatment of syphilis. Seminars in ophthalmology. Taylor & Francis, pp 161–167. Published online 2 Jul, 2009
Tucker JD, Li JZ, Robbins GK et al (2011) Ocular syphilis among HIV-infected patients: a systematic analysis of the literature. Sex Transm Infect 87:4–8
Gaudio PA (2006) Update on ocular syphilis. Curr Opin Ophthalmol 17:562–566
Shalaby IA, Dunn JP, Semba RD et al (1997) Syphilitic uveitis in human immunodeficiency virus—infected patients. Arch Ophthalmol 115:469–473
Hooshmand H, Escobar MR, Kopf SW (1972) Neurosyphilis: a study of 241 patients. JAMA 219:726–729
Holmes MD, Brant-Zawadzki MM, Simon RP (1984) Clinical features of meningovascular syphilis. Neurology 34:553
Harrigan EP, McLaughlin TJ, Feldman RG (1984) Transverse myelitis due to meningovascular syphilis. Arch Neurol 41:337–338
Luo W, Ouyang Z, Xu H et al (2008) The clinical analysis of general paresis with 5 cases. J Neuropsychiatry Clin Neurosci 20:490–493
Hattori T, Yasuda K, Kita K et al (1990) Disorders of micturition in tabes dorsalis. Br J Urol 65:497–499
Osman C, Clark T, Ghosh B et al (2015) Tabes dorsalis in the post antibiotic era: never say never. J Neurol Neurosurg Psychiatry e4:86
Musher DM, Baughn RE (1994) Neurosyphilis in HIV-infected persons. N Engl J Med 331:1516–1517
Kingston AA, Vujevich J, Shapiro M et al (2005) Seronegative secondary syphilis in 2 patients coinfected with human immunodeficiency virus. Arch Dermatol 141:431–433
Workowski KA, Bolan GA (2015) Sexually transmitted diseases treatment guidelines. Reprod Endocrinol 24:51–56
Ghanem KG, Moore RD, Rompalo AM et al (2009) Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 48:816–821
Yang C, Chang S, Hung C (2009) Sensitivity and specificity of lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 49:162
Ratnam S (2005) The laboratory diagnosis of syphilis. Can J Infect Dis Med Microbiol 16:45–51
Larsen SA, Pope V, Johnson RE et al (2008) A manual of tests for syphilis. Washington, DC: American Public Health Association, 1998. Anaesth Intensive Care 36:260–272
Smith G, Holman RP (2004) The prozone phenomenon with syphilis and HIV-1 co-infection. South Med J 97:379–383
Hagedorn H, Kraminer-Hagedorn A, De Bosschere K et al (2002) Evaluation of INNO-LIA syphilis assay as a confirmatory test for syphilis. J Clin Microbiol 40:973–978
Wicher K, Horowitz HW, Wicher V (1999) Laboratory methods of diagnosis of syphilis for the beginning of the third millennium. Microb Infect 1:1035–1049
Castro RR, Prieto ES, Santo I et al (2001) Evaluation of the passive particle agglutination test in the serodiagnosis and follow-up of syphilis. Am J Clin Pathol 116:581–585
Gutirrez J, Vergara MJ, Soto MJ et al (2000) Clinical utility of a competitive ELISA to detect antibodies against Treponema pallidum. J Clin Lab Anal 14:83–86
Byrne RE, Laska S, Bell M et al (1992) Evaluation of a Treponema pallidum western immunoblot assay as a confirmatory test for syphilis. J Clin Microbiol 30:115–122
Sambri V, Marangoni A, Eyer C et al (2001) Western immunoblotting with five Treponema pallidum recombinant antigens for serologic diagnosis of syphilis. Clin Diagn Lab Immunol 8:534–539
Herring AJ, Ballard RC, Pope V et al (2006) A multi-centre evaluation of nine rapid, point-of-care syphilis tests using archived sera. Sex Transm Infect v12:82
Peeling RW, Holmes KK, Mabey D et al (2006) Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect v6:82
Libois A, De Wit S, Poll B et al (2007) HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 34:141–144
Chan DJ (2005) Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr HIV Res 3:95–98
Lwhagen GB (1990). Syphilis: test procedures and therapeutic strategies. Semin Dermatol. 1990 Jun; 9(2):152–9
Davis LE, Schmitt JW (1989) Clinical significance of cerebrospinal fluid tests for neurosyphilis. Ann Neurol 25:50–55
Marra CM, Maxwell CL, Tantalo LC et al (2008) Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 47:893–899
Marra CM, Maxwell CL, Smith SL et al (2004) Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 189:369–376
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Addisu, A., Casanas, B., Alrabaa, S. (2017). Neurosyphilis and HIV Infection. In: Shapshak, P., et al. Global Virology II - HIV and NeuroAIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7290-6_27
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7290-6_27
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7288-3
Online ISBN: 978-1-4939-7290-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)